Our data for the first time identified an inhibitory effect of UBA1 inhibitor PYR-41 in atherosclerosis, therefore might expand the therapeutic potent of UBA1 as a potential pharmaceutical target against atherosclerosis. Here, UBA1 is linked to atherosclerosis.